Abstract
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006. They stimulate insulin secretion and inhibit glucagon secretion by elev......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
